Navigation Links
Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
Date:7/31/2008

JERUSALEM, July 31 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that it will hold a conference call on August 6, 2008 at 10:30 AM EDT to present the results of its Phase 2A clinical trials of its flagship product, ORMD 0801, an oral insulin capsule.

Oramed's Phase 2A trial is focused on assessing the safety and efficacy of ORMD 0801. This study is a continuation of the successfully completed Phase 1 studies in Israel.
Interested parties should dial:

In the United States: +1-888-668-9141

All other locations: +972-3-918-0691

About Oramed Pharmaceuticals Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
2. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
3. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
5. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
6. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
7. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
8. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
9. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
10. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
11. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasd..., November 10, 2009 at 8:30 a.m. EST to discuss th...s outlook for the remainder of 2009. Ron Bentsur,... the call. Keryx will announce its financial resu...d prior to the call. ,, In order to participate...
(Date:11/6/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...l results for the second quarter ended October 23,...Wednesday, November 18, 2009 at 5:00 PM EST. The ...those results on Thursday, November 19, 2009 at 9:... Results Conference Call Instructions ,, To l...
(Date:11/6/2009).../ -- NexBio Inc., in collaboration with scientists... (CDC), St. Louis University, and the University o...o articles in the peer-reviewed journal PLoS ONE. ...Fludase ® ) may play a potentially important ...mic Influenza A(H1N1) and drug-resistant influenza...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4ForteBio Launches Two Revolutionary High Throughput Label Free Instruments 3A The Octet 28R 29 RED384 and the Octet QK384 12733 1ForteBio Launches Two Revolutionary High Throughput Label Free Instruments 3A The Octet 28R 29 RED384 and the Octet QK384 12733 2ForteBio Launches Two Revolutionary High Throughput Label Free Instruments 3A The Octet 28R 29 RED384 and the Octet QK384 12733 3Music Can Make the Heart Beat Faster 49672 1Music Can Make the Heart Beat Faster 49672 2Music Can Make the Heart Beat Faster 49672 3Patients Often Not Told About Abnormal Test Results 49670 1Patients Often Not Told About Abnormal Test Results 49670 2Patients Often Not Told About Abnormal Test Results 49670 3
(Date:11/8/2009)... Calls for Swift Passage of H.R. 3961 to Secure th...Newswire-USNewswire/ -- Statement Attributable to:...l Association. ,, (Logo: http://www.newscom.c...A hails the passage of the House health reform bil...atients and physicians and calls for swift passage...
(Date:11/8/2009)... AARP Praises House Passage of Health Care Reform ... Medicare, improve coverage for all Americans ,...UMMARY: Tonight the United States House of Repres...lation that would strengthen Medicare for seniors ... prices millions of Americans out of affordable he...
(Date:11/7/2009)...HOUSTON, Nov. 7, The Am... 2009 Benjamin Rush Award for Citizenship and Comm...ologist from Chicago, IL. The award recognizes phy...ssional call of duty to make an outstanding public.... Kraff received the award today during the openin...
(Date:11/7/2009)...HOUSTON, Nov. 7 Members...roduce an emergency resolution rescinding the AMA,...ysicians that they are responsible to their PATIEN...erkes, Director of Policy for the Association of A...icine, a coalition of other medical groups. ,,...
(Date:11/7/2009)...WASHINGTON, Nov. 7 Spea...ss availability this afternoon following a Democra...n Caucus Room. Below are the Speaker,s opening re..., it was a great occasion for us to receive the Pr...ill be making history with our vote and making pro...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...invasive treatment for a common cause of male infe...es for pregnancy, according to a new study publish...nducted at the University of Bonn in Germany, also...r through the groin, can help to improve sperm fun...
...ve one removed than men, study shows , , M...icans who get tattoos are happy with their decisio...o get their markings removed, new research reveals...ments as a result of having a tattoo. , "We saw th...
...er oral health problems continue to change as she ...dentists in Second Life,s virtual dental office. ...a new research project of the Case Western Reserve...me to communicate with mock patients. , Not only...
...r, all menopause women think that only hormones ca...s that cool herbs can cool down hot flashes not on... Ann Arbor, MI (PRWEB) July 21, 2008 -- Th... much complicated information overwhelms menopause...
...itute of Harvard and MIT have received a grant to ...ng ways to encourage the human body to replenish t...ded by the Juvenile Diabetes Research Foundation (...estion in human biology: can existing cells be coa...
...e for Advanced Medical,Education (IAME) announces ...iopsy, its much-awaited online CME program. Produc...aging community, this course offers the 3 CME,cred...r of IAME,s website at, http://www.iame.com/sbb_fr...
Other Medicine News:Health News:Minimally invasive treatment improves male fertility 2Health News:Women More Likely to Have Second Thoughts on Tattoos 2Health News:Women More Likely to Have Second Thoughts on Tattoos 3Health News:A virtual toothache helps student dentists 2Health News:A virtual toothache helps student dentists 3Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 2Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 3Health News:Broad Institute earns grant to support pathbreaking diabetes study 2Health News:Broad Institute earns grant to support pathbreaking diabetes study 3
Finnpipette Focus Fixed Volume, 10ul
...Eppendorf Reference Series 2000 Pipette is a synon...act and robust design, and superior operating comf... operate the measuring stroke and blow-out as well...ette/tip" system ensures utmost accuracy and preci...
Pipetman F25
...Eppendorf Reference Series 2000 Pipette is a synon...act and robust design, and superior operating comf... operate the measuring stroke and blow-out as well...ette/tip" system ensures utmost accuracy and preci...
Medicine Products: